CPPI News |

June 8, 2021
By cppiadmin
No Comments

CPPI Statement on HHS Importation Case Filing

in Big Pharma, Consumer Impact, CPPI News, Drug prices

BigPharma Has No Case Against Importation Asserts HHS Washington, DC - The Campaign for Personal Prescription Importation released the following statement regarding the Health and Human Services motion to dismiss Case No. 1:20-cv-03402-TJK, regarding a…

May 27, 2021
By cppiadmin
No Comments

American Patients’ Medication Access Constrained by Credit Card Processing

in Consumer Impact, CPPI News, Drug prices

In a survey of American patients who import medications conducted by the Campaign for Personal Prescription Importation, 89% say that lifting restrictions on credit card processing for international online prescription drug purchases would ease access…

May 4, 2021
By cppiadmin
No Comments

GAO Confirms Safety of Drugs From Overseas

in Big Pharma, Consumer Impact, CPPI News, Drug prices, Rogues, Safety

Tens of millions of Americans can't afford their prescription drugs and the debate over how to ensure access to affordable drugs is hotly contested. One of the biggest strawman arguments propped up by Big Pharma…

April 22, 2021
By cppiadmin
No Comments

Short Survey on Rx Payments

in Consumer Impact, CPPI News

We are seeking responses on a NEW Short Survey to help us better advocate for American patients seeking access to affordable medications from abroad.

March 26, 2021
By cppiadmin
No Comments

Fresh Congressional Action

in Consumer Impact, CPPI News, Drug prices

The Campaign for Personal Prescription Importation (CPPI) applauds the U.S. Senators and Representatives who introduced and co-sponsored the Affordable and Safe Prescription Drug Importation Act of 2021. This legislation was introduced on March 23rd, at…

March 22, 2021
By cppiadmin
No Comments

Americans’ Best Rx Prices Found at Online Canadian Pharmacies Over Amazon, GoodRx & Leading U.S. Competitors

in Big Pharma, Consumer Impact, CPPI News, Drug prices

Washington, D.C. - A new price comparison of prescription drugs finds online Canadian pharmacy prices 50 to 90% more affordable than prices at AmazonPharmacy, GoodRx and leading U.S. pharmacy competitors. The analysis by the Campaign…

March 4, 2021
By cppiadmin
No Comments

STATEMENT on Safe and Affordable Drugs from Canada Act of 2021

in Consumer Impact, CPPI News, Drug prices

March 4, 2021 The Campaign for Personal Prescription Importation cheers the U.S. Senators and Representatives who introduced and co-sponsored the Safe and Affordable Drugs from Canada Act of 2021, which would allow individuals to safely…

February 22, 2021
By cppiadmin
No Comments

SURVEY RESULTS: Importing Prescription Drugs Saves Americans an Average $2.7k/Yr

in Big Pharma, Consumer Impact, CPPI News, Drug prices

High Drug Prices Remain A Top Public Policy Priority; 99 Percent Recommend RxImportation WASHINGTON, D.C. – In survey results released today by the Campaign for Personal Prescription Importation (CPPI) Americans reported saving an average of…

February 10, 2021
By cppiadmin
No Comments

U.S. prices 344% of prices in non-U.S. countries for the same brand name drugs

in Big Pharma, Consumer Impact, CPPI News, Drug prices

Prescription drug prices in the United States are an average of 2.56 times higher than those seen in 32 other nations, according to a new RAND Corporation report. The price gap was even bigger for…

January 19, 2021
By Jack Pfeiffer
No Comments

Washington Forecast: President Biden, 117th Congress & Drug Prices

in Consumer Impact, CPPI News

On January 20, 2021, Joe Biden, will be sworn in as the 46th president of the United States. What will Biden’s presidency and a new congress mean for U.S. prescription drug costs? CPPI examines the…

Category Archives: CPPI News